Can SGLT2 Inhibitors ERASe Arrhythmias?

Michael Colacci^{1

2}, Mats C Højbjerg Lassen^{3

4

5}

Affiliations

¹ Department of Medicine, University of Toronto, Toronto, ON.
² Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON.
³ Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Gentofte Hospitalsvej, Copenhagen.
⁴ Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Gentofte Hospitalsvej, Hellerup.
⁵ Department of Medicine, Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston.

Editorial

Michael Colacci et al. NEJM Evid. 2024 Oct.

. 2024 Oct;3(10):EVIDe2400277.

doi: 10.1056/EVIDe2400277. Epub 2024 Sep 24.

Michael Colacci^{1

2}, Mats C Højbjerg Lassen^{3

4

5}

¹ Department of Medicine, University of Toronto, Toronto, ON.
² Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON.
³ Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Gentofte Hospitalsvej, Copenhagen.
⁴ Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Gentofte Hospitalsvej, Hellerup.
⁵ Department of Medicine, Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston.

No abstract available

Comment on

Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs/CRT-Ds.
Benedikt M, Oulhaj A, Rohrer U, Manninger M, Tripolt NJ, Pferschy PN, Aziz F, Wallner M, Kolesnik E, Gwechenberger M, Martinek M, Nürnberg M, Roithinger FX, Steinwender C, Widkal J, Leiter S, Zirlik A, Stühlinger M, Scherr D, Sourij H, von Lewinski D. Benedikt M, et al. NEJM Evid. 2024 Oct;3(10):EVIDoa2400147. doi: 10.1056/EVIDoa2400147. Epub 2024 Sep 1. NEJM Evid. 2024. PMID: 39217453 Clinical Trial.